Jul 2026 (Q2 FY27) — Aug 27, 2026
HealthEquity Q2 FY27 — Record Adjusted EBITDA Margin and Raised FY27 Guidance
Read the full callHealthEquity (HQY) earnings
- Jul 2026
- Jul 2026 (Q2 FY27)
- Jan 2026
HealthEquity earnings: last reported Thu, 27 Aug 2026, for the quarter ended Jul 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 351 | +7.6% YoY | Quarterly, as filed | Quarter to Jul 2026 | Revenue from operations as filed. |
| Operating margin | 28.1 | +0.6 pts YoY | Operating profit / revenue | Quarter to Jul 2026 | For the quarter; a change is in percentage points. |
| Net profit | 65.6 | +9.7% YoY | Quarterly, as filed | Quarter to Jul 2026 | Profit after tax as filed. |
Price
$93.07 +1.13% · +$1.04
Performance +1.8% 1Y
1Y: $91.46 on 17 Oct 2025 → $93.07. High $106.79 (10 Aug 2026), low $73.21 (12 Feb 2026).
- Previous close
- $92.03
- 52-week range
- $73.21 – $106.79
- One year
- +0.04%
Overview
- Symbol
- HQY
- Sector
- Health Care
- Exchange
- US
- Currency
- USD
Call summaries
Apr 2026 (Q1 FY27) — May 28, 2026
HealthEquity Q1 FY27 — Strong Profitability and Raised FY27 Guidance
Read the full callJan 2026 (Q4 FY26) — Mar 17, 2026
HealthEquity Q4 FY26 — Record HSA Sales and Strong Margin Expansion
Read the full callEvery analysed call
HealthEquity earnings calls (HQY)
Financials
What the filings say
Net profit, year on year: +10% (quarter to jul 2026 against jul 2025).
| Line item | Oct 2024 | Jan 2025 | Apr 2025 | Jul 2025 | Oct 2025 | Jan 2026 | Apr 2026 | Jul 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 300 | 312 | 331 | 326 | 322 | 335 | 355 | 351 |
| Operating profit | 20 | 42 | 83 | 90 | 79 | 71 | 103 | 99 |
| Operating margin | 6.5% | 13.5% | 25.1% | 27.5% | 24.4% | 21.2% | 29.0% | 28.1% |
| Other income | -13 | -12 | -12 | -12 | -11 | -10 | -11 | -11 |
| Interest | 18 | 15 | 15 | 15 | 14 | 13 | 13 | 13 |
| Profit before tax | 6 | 30 | 71 | 78 | 68 | 61 | 92 | 88 |
| Tax rate | 8.3% | 12.0% | 24.0% | 23.3% | 23.5% | 18.3% | 24.9% | 25.3% |
| Net profit | 6 | 26 | 54 | 60 | 52 | 50 | 69 | 66 |
| EPS ($ per share) | 0.07 | — | 0.62 | 0.69 | 0.60 | — | 0.82 | 0.79 |
| Line item | Jan 2019 | Jan 2020 | Jan 2021 | Jan 2022 | Jan 2023 | Jan 2024 | Jan 2025 | Jan 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reserves | 172 | 212 | 220 | 176 | 150 | 206 | 209 | 196 |
| Total liabilities | 33 | 1,535 | 1,332 | 1,255 | 1,193 | 1,129 | 1,334 | 1,273 |
| Fixed assets | 8 | 33 | 29 | 23 | 13 | 6 | 3 | 3 |
| Total assets | 510 | 2,565 | 2,710 | 3,107 | 3,089 | 3,164 | 3,449 | 3,380 |
| Line item | Jan 2019 | Jan 2020 | Jan 2021 | Jan 2022 | Jan 2023 | Jan 2024 | Jan 2025 | Jan 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 113 | 105 | 182 | 141 | 151 | 243 | 340 | 457 |
| Cash from investing | 26 | -1,740 | -97 | -639 | -119 | -46 | -505 | -47 |
| Cash from financing | 23 | 1,466 | 52 | 395 | -3 | -47 | 58 | -387 |
| Net cash flow | 162 | -170 | 137 | -103 | 29 | 150 | -108 | 23 |
| Capital expenditure | -4 | -7 | -13 | -9 | -3 | -2 | -2 | -2 |
| Free cash flow | 110 | 98 | 169 | 132 | 147 | 241 | 338 | 455 |
HQY revenue by segment
Service shrank from 40% to 35% of revenue over the last two years.
| Segment | Q3 FY2025 | Q4 FY2025 | Q1 FY2026 | Q2 FY2026 | Q3 FY2026 | Q4 FY2026 | Q1 FY2027 | Q2 FY2027 | YoY growth latest quarter |
|---|---|---|---|---|---|---|---|---|---|
| Service | 40% | 40% | 36% | 36% | 37% | 38% | 35% | 35% | +5.6% |
| Credit and Debit Card | 13% | 14% | 17% | 15% | 13% | 14% | 16% | 14% | +4.7% |
Share of consolidated revenue by quarter. Q4 is the fiscal year less its first three quarters.
See how segments are shifting across companies → Segment Shift
HQY operating KPIs by quarter
| KPI | Jan 2026 Q4 FY26 | Apr 2026 Q1 FY27 | Jul 2026 Q2 FY27 | Change vs prior quarter |
|---|---|---|---|---|
| New HSAs added | 550KIn the fourth quarter, we delivered 23% adjusted EBITDA growth and more than 500 basis points of adjusted EBITDA margin expansion, while adding a record 550,000 HSAs, resulting in more than 1 million new HSAs from sales for the year, bringing total accounts to 17.8 million and HSA Assets to more than $36 billion.Source: earnings call transcript | 172KNew HSAs from sales grew 15%, introducing 172,000 new HSAs to our platform.Source: earnings call transcript | — | -68.7% |
| App downloads | 3.6M+We now have more than 3.6 million downloads of our app, reflecting the growing adoption of digital-first healthcare.Source: earnings call transcript | — | 5M+Monthly active users on the app reached 1.4 million in July, up 62% year-over-year, while total app downloads exceeded 5 million.Source: earnings call transcript | — |
| Clients | 100K+That level of growth reflects the deeply integrated proprietary compliant platform with more than 200 network partners in over 100,000 clients, supported by a member first secure mobile experience.Source: earnings call transcript | — | ~100KSo, look, I mean, one of the benefits of having around 100,000 or more clients is we see all different types, right?Source: earnings call transcript | — |
Operating figures the company stated on at least two of the calls shown, checked against each call's transcript. Click a figure to read the sentence. A dash means it was not stated that quarter.
Insider filings
66 filings between Oct 20, 2025 and Oct 6, 2026.
Open market
decisions to buy or sellPurchases
None
No insider bought shares.
Sales
$4.36M
12 sales by 5 insiders
83% filed under a 10b5-1 plan — scheduled in advance, not decided on the day
Compensation
not trading decisions- 20
- Award — granted as compensation
- 3
- Option exercise — converted options into shares
- 27
- Tax withheld — shares kept back by the company to cover tax
Also filed: 4 gifts.
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Ladd Delano | — | $1.11M | May 28, 2026 |
| Rosner Elimelech | — | $1.05M | Dec 18, 2025 |
| DILLON ADRIAN T | — | $798.4K | Aug 25, 2026 |
| Fiore Michael Henry | — | $756.8K | Jul 10, 2026 |
| Wellborn Gayle Furgurson | — | $644.8K | May 28, 2026 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Oct 6, 2026 | Lucania James M EVP & CFO | Tax withheld | 2,822 | $257.2K |
| Oct 6, 2026 | Ladd Delano EVP, General Counsel | Tax withheld | 1,080 | $98.4K |
| Oct 6, 2026 | Cutler Scott President and CEO | Tax withheld | 1,230 | $112.1K |
| Oct 6, 2026 | Fiore Michael Henry Insider | Tax withheld | 2,032 | $185.2K |
| Oct 6, 2026 | Neeleman Stephen FOUNDER AND VICE CHAIRMAN | Tax withheld | 1,095 | $99.8K |
| Oct 6, 2026 | Gathright Michael Chief Customer Officer | Tax withheld | 662 | $60.3K |
| Sep 17, 2026 | Neeleman Stephen FOUNDER AND VICE CHAIRMAN | Gift | 1,500 | $0 |
| Aug 25, 2026 | DILLON ADRIAN T Director | Sale 10b5-1 plan | 6,300 | $658.2K |
| Aug 25, 2026 | DILLON ADRIAN T Director | Sale 10b5-1 plan | 1,332 | $140.2K |
| Aug 25, 2026 | DILLON ADRIAN T Director | Option exercise 10b5-1 plan | 7,632 | $248.0K |
| Jul 10, 2026 | Fiore Michael Henry EVP, CHIEF COMMERCIAL OFFICER | Sale 10b5-1 plan | 2,354 | $223.6K |
| Jul 9, 2026 | Gathright Michael Chief Customer Officer | Tax withheld | 2,270 | $211.3K |
| Jul 8, 2026 | Fiore Michael Henry EVP, CHIEF COMMERCIAL OFFICER | Tax withheld | 2,045 | $194.4K |
| Jul 8, 2026 | Cutler Scott President and CEO | Tax withheld | 1,238 | $117.7K |
| Jul 8, 2026 | Ladd Delano EVP, General Counsel | Tax withheld | 1,087 | $103.4K |
| Jul 8, 2026 | Lucania James M EVP & CFO | Tax withheld | 2,839 | $269.9K |
| Jul 8, 2026 | Neeleman Stephen FOUNDER AND VICE CHAIRMAN | Tax withheld | 1,103 | $104.9K |
| Jul 2, 2026 | Fiore Michael Henry EVP, CHIEF COMMERCIAL OFFICER | Sale 10b5-1 plan | 2,470 | $234.7K |
| Jun 25, 2026 | Parker Stuart B. Director | Award | 2,877 | $0 |
| Jun 25, 2026 | Natarajan Rajesh Director | Award | 2,877 | $0 |
| Jun 25, 2026 | McCowan Debra Charlotte Director | Award | 2,877 | $0 |
| Jun 25, 2026 | Wellborn Gayle Furgurson Director | Award | 2,877 | $0 |
| Jun 25, 2026 | Dilsaver Evelyn S Director | Award | 2,877 | $0 |
| Jun 25, 2026 | DILLON ADRIAN T Director | Award | 2,877 | $0 |
| Jun 25, 2026 | SELANDER ROBERT W Director | Award | 2,877 | $0 |
| Jun 25, 2026 | Gassen William Director | Award | 2,877 | $0 |
| May 29, 2026 | Fiore Michael Henry EVP, CHIEF COMMERCIAL OFFICER | Sale 10b5-1 plan | 3,142 | $298.5K |
| May 28, 2026 | Wellborn Gayle Furgurson Director | Option exercise 10b5-1 plan | 2,439 | $115.1K |
| May 28, 2026 | Ladd Delano EVP, General Counsel | Sale 10b5-1 plan | 7,500 | $675.0K |
| May 28, 2026 | Wellborn Gayle Furgurson Director | Sale 10b5-1 plan | 2,439 | $219.5K |
| Apr 6, 2026 | Neeleman Stephen FOUNDER AND VICE CHAIRMAN | Tax withheld | 2,559 | $214.5K |
| Apr 6, 2026 | Fiore Michael Henry EVP, CHIEF COMMERCIAL OFFICER | Tax withheld | 3,378 | $283.2K |
| Apr 6, 2026 | Rosner Elimelech EVP, CHIEF TECHNOLOGY OFFICER | Tax withheld | 4,768 | $399.7K |
| Apr 6, 2026 | Cutler Scott President and CEO | Tax withheld | 4,931 | $413.4K |
| Apr 6, 2026 | Ladd Delano EVP, General Counsel | Tax withheld | 2,481 | $208.0K |
| Apr 6, 2026 | Lucania James M EVP & CFO | Tax withheld | 4,393 | $368.3K |
| Mar 31, 2026 | Rosner Elimelech EVP, CHIEF TECHNOLOGY OFFICER | Tax withheld | 18,010 | $1.49M |
| Mar 31, 2026 | Ladd Delano EVP, General Counsel | Tax withheld | 7,726 | $637.6K |
| Mar 31, 2026 | Neeleman Stephen FOUNDER AND VICE CHAIRMAN | Tax withheld | 9,292 | $766.8K |
| Mar 25, 2026 | Neeleman Stephen FOUNDER AND VICE CHAIRMAN | Award | 23,860 | $0 |
| Mar 25, 2026 | Lucania James M EVP & CFO | Award | 27,283 | $0 |
| Mar 25, 2026 | Neeleman Stephen FOUNDER AND VICE CHAIRMAN | Award | 15,915 | $0 |
| Mar 25, 2026 | Gathright Michael Chief Customer Officer | Award | 15,157 | $0 |
| Mar 25, 2026 | Fiore Michael Henry EVP, CHIEF COMMERCIAL OFFICER | Award | 17,582 | $0 |
| Mar 25, 2026 | Rosner Elimelech EVP, CHIEF TECHNOLOGY OFFICER | Award | 40,903 | $0 |
| Mar 25, 2026 | Rosner Elimelech EVP, CHIEF TECHNOLOGY OFFICER | Award | 19,704 | $0 |
| Mar 25, 2026 | Cutler Scott President and CEO | Award | 72,754 | $0 |
| Mar 25, 2026 | Ladd Delano EVP, General Counsel | Award | 20,451 | $0 |
| Mar 25, 2026 | Ladd Delano EVP, General Counsel | Award | 15,157 | $0 |
| Feb 2, 2026 | Natarajan Rajesh Director | Award | 976 | $0 |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for HEALTHEQUITY, INC.
Free account. Everything above stays public.
Write why you follow HEALTHEQUITY, INC. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading